Residex.AI Acquires Kevala to Strengthen Senior Care Technology Platform

Residex.AI, a prominent provider of Electronic Health Record (EHR) and clinical electronic Medication Administration Record (eMAR) for senior living communities, has completed the acquisition of Kevala, an AI-powered workforce management platform. This move bolsters Residex's position in the senior care technology market by adding staffing optimization to its clinical assessment, incident management, and care planning platform. The acquisition comes at a critical time for senior care facilities facing challenges such as staffing shortages, rising operational costs, and increasing regulatory requirements.

Residex's comprehensive platform manages resident health records, medication administration, care planning, assessments, and clinical documentation. By integrating Kevala's AI solution, Quin™, specialized in workforce optimization and predictive scheduling based on resident acuity levels and staff qualifications, the combined platform aims to ensure quality care delivery both clinically and operationally. Chris Poelma, CEO of Residex.AI, expressed the strategic significance of the acquisition, highlighting the complementary nature of Kevala's workforce management approach with their clinical platform.

The goal is to create an integrated solution managing both clinical operations and workforce optimization. Todd Owens, CEO and Co-Founder of Kevala, echoed the sentiments, emphasizing the potential of the acquisition to bring transformative AI capabilities to a broader community of senior care providers.

Residex.AI provides a comprehensive AI-enabled EHR and clinical eMAR platform designed specifically for senior living communities. Kevala, on the other hand, offers AI-powered workforce management technology through its flagship solution, Quin™, which optimizes staffing schedules, tracks credentials, and predicts staffing needs in senior care facilities.